Effectiveness of a Prehabilitation Program for Hip or Knee Arthroplasty Surgery.
Launched by IRENE MARÍA LOPERA PAREJA · Dec 3, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating the benefits of a prehabilitation program for patients who are preparing to undergo hip or knee replacement surgery, also known as arthroplasty. Prehabilitation involves specific exercises and physical therapy designed to improve a patient’s strength and overall health before surgery. The goal of this study is to see if participating in this program can help patients recover faster after their surgery, improve their physical abilities, and enhance their mental well-being.
To be eligible for this trial, participants must have a diagnosis of osteoarthritis in their hip or knee and be scheduled for surgery. They should be able to perform a basic movement test and walk with little to no assistance. However, those with certain medical conditions, such as dementia, cancer, or other serious health issues that might interfere with exercise, cannot participate. If you join this study, you can expect to take part in a supportive exercise program that aims to prepare you for surgery and hopefully lead to a quicker and smoother recovery process.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of hip OA stage I-III of the Tönnis classification or diagnosis of knee OA stage I-IV of the Ahlbäck classification
- • Patients requiring hip/knee arthroplasty surgery
- • Signed informed consent
- • Obtaining a score equal to or greater than 8 repetitions in the Sit to Stand test
- • Patients with the ability to walk without technical aids or in need of some help (up to two canes or a walker)
- Exclusion Criteria:
- • Cognitive deficit/Dementia states
- • Cancer processes
- • Associated vascular and inflammatory pathologies
- • Associated neurological pathologies
- • Contraindications to physical exercise
About Irene María Lopera Pareja
Irene María Lopera Pareja is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study designs and rigorous scientific methodologies. With a focus on ethical practices and regulatory compliance, Ms. Lopera Pareja leads initiatives that explore novel therapeutic approaches across various fields. Her extensive expertise in clinical operations, coupled with a passion for patient-centered research, drives the development of trials that aim to address unmet medical needs and contribute to the growing body of evidence in healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Marbella, , Spain
Patients applied
Trial Officials
IRENE MARIA IMLP LOPERA PAREJA, PRINCIPAL INVESTIGATOR
Principal Investigator
University of Jaen
IRENE MARIA IM LOPERA, Investigator
Principal Investigator
University of Jaen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported